Behind the Report: Exploring Long-Acting Injectable Buprenorphine Provision Across Scotland

Following on from the recent 'Evaluation of Exploring Long-Acting Injectable Buprenorphine Provision Across Scotland', Louise Horn (Peer Research Development Officer, SDF) and Jacqui (Peer Researcher, SDF) join Kirsten Horsburgh, CEO of Scottish Drugs Forum, and Jason Wallace, Programme Manager for Lived and Living Experience, to discuss the research behind the report.

They explore the peer research process, key findings and recommendations, alongside the real experiences of those accessing the treatment in Scotland.

You can read the full report here: https://sdf.org.uk/wp-content/uploads/2025/08/Evaluation-of-Exploring-Long-Acting-Injectable-Buprenorphine-Provision-Across-Scotland-August-2025.pdf

And the Executive Summary here: https://sdf.org.uk/wp-content/uploads/2025/08/Evaluation-of-Exploring-Long-Acting-Injectable-Buprenorphine-Provision-Across-Scotland-SDF-August-2025-Executive-Summary.pdf